Neurocrine Biosciences, Inc. (NBIX): Price and Financial Metrics


Neurocrine Biosciences, Inc. (NBIX)

Today's Latest Price: $94.31 USD

3.09 (3.39%)

Updated Apr 7 8:00pm

Add NBIX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

NBIX Stock Summary

  • NBIX's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 429.96 -- higher than 93.17% of US-listed equities with positive expected earnings growth.
  • NBIX's current price/earnings ratio is 214.56, which is higher than 98.29% of US stocks with positive earnings.
  • The price/operating cash flow metric for Neurocrine Biosciences Inc is higher than 95.8% of stocks in our set with a positive cash flow.
  • If you're looking for stocks that are quantitatively similar to Neurocrine Biosciences Inc, a group of peers worth examining would be SSTI, NTCT, BLKB, MITK, and GDDY.
  • NBIX's SEC filings can be seen here. And to visit Neurocrine Biosciences Inc's official web site, go to www.neurocrine.com.
NBIX Daily Price Range
NBIX 52-Week Price Range

NBIX Stock Price Chart More Charts


NBIX Price/Volume Stats

Current price $94.31 52-week high $119.65
Prev. close $91.22 52-week low $71.85
Day low $91.62 Volume 808,800
Day high $95.91 Avg. volume 846,276
50-day MA $93.91 Dividend yield N/A
200-day MA $98.01 Market Cap 8.70B

Neurocrine Biosciences, Inc. (NBIX) Company Bio


Neurocrine Biosciences discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company was founded in 1992 and is based in San Diego, California.


NBIX Latest News Stream


Event/TimeNews Detail
Loading, please wait...

NBIX Latest Social Stream


Loading social stream, please wait...

View Full NBIX Social Stream

NBIX Price Returns

1-mo 6.63%
3-mo -17.10%
6-mo 4.41%
1-year 5.60%
3-year 130.70%
5-year 120.81%
YTD -12.26%
2019 50.53%
2018 -7.96%
2017 100.49%
2016 -31.59%
2015 153.22%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.759 seconds.